ScreenerHero

HIMS Hims & Hers Health, Inc.

NYSE · US · Healthcare · Drug Manufacturers - Specialty & Generic · hims.com
29.67USD+2.31%Mkt Cap: 6.92B $P/E: —

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of I…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited
$56.90BUSD
TEVA
Teva Pharmaceutical Industries Limited
$46.26BUSDP/E 66.1
HLN
Haleon plc
$38.79BUSDP/E 18.0
ZTS
Zoetis Inc.
$29.51BUSDP/E 11.7
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
UTHR
United Therapeutics Corporation
$23.01BUSDP/E 19.2
VTRS
Viatris Inc.
$20.24BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc.
$14.66BUSDP/E 21.1
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated
$11.25BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.26BUSDP/E 28.0
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
ALKS
Alkermes plc
$7.17BUSDP/E 112.5
AMRX
Amneal Pharmaceuticals, Inc.
$7.09BUSDP/E 41.5
LNTH
Lantheus Holdings, Inc.
$6.54BUSDP/E 24.3
KNSA
Kiniksa Pharmaceuticals International, plc
$5.87BUSDP/E 77.1
APTX
Apotex Health Corp.
$5.17BUSD
INDV
Indivior Pharmaceuticals, Inc.
$4.25BUSDP/E 12.9

Key Statistics

Company
Market Cap6.92B USD
Enterprise Value7.47B USD
Revenue (TTM)2.58B USD
Gross Profit1.73B USD
Net Income (TTM)128.37M USD
Revenue/Share11.29 USD
Last Price29.67 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.4K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)39.33
PEG2.64
EV/EBITDA-734.13
EV/Revenue2.90
P/S2.62
P/B20.88
EPS (TTM)-0.64
EPS (Forward)0.74
52W Range
13.7431% of range65.30
52W High65.30 USD
52W Low13.74 USD
Profitability
Gross Margin73.84%
Oper. Margin-12.75%
EBITDA Margin-0.40%
Profit Margin5.47%
ROE23.73%
ROA5.96%
Growth
Revenue Growth38.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF300.01M USD
CapEx (TTM)242.59M USD
FCF Margin32.95%
FCF Yield12.27%
Net Debt705.19M USD
Net Debt/EBITDA-69.29
Balance Sheet
Debt/Equity2.07
Current Ratio0.93
Quick Ratio0.82
Book Value/Sh1.39 USD
Cash/Share3.60 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.8 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)31.15 USD
Upside (mean)+5.0%
Target Range23.00 USD – 42.00 USD
23.00+5.0% to mean42.00
# Analysts13
Ownership
Shares Out.224.94M
Float213.74M
Insiders4.95%
Institutions71.15%
Short Interest
Short Ratio4.9d
Short % Float27.26%
Short % Out.22.68%
Shares Short52.92M
Short (prev mo.)58.67M
Technical
SMA 5029.29 (+1.3%)
SMA 20027.54 (+7.7%)
Beta2.41
S&P 52W Chg14.58%
Avg Vol (30d)9.62M
Avg Vol (10d)10.75M
Technical Indicators
RSI (14)52.5
MACD-0.0229
MACD Signal-0.1933
MACD Hist.+0.1704
BB Upper30.35 USD
BB Middle28.68 USD
BB Lower27.01 USD
BB Width11.65%
ATR (14)1.704 USD
Vol Ratio (20d)0.79x